Great Tree Pharmacy Co., Ltd. (TPEX:6469)
57.80
-2.40 (-3.99%)
Nov 6, 2026, 1:30 PM CST
Great Tree Pharmacy Revenue
Great Tree Pharmacy had revenue of 4.74B TWD in the quarter ending June 30, 2026, a decrease of -0.97%. This brings the company's total for the last twelve months to 19.02B, up 4.00% year-over-year. In the year 2025, Great Tree Pharmacy had annual revenue of 18.90B with 9.39% growth. That makes Great Tree Pharmacy the 10,428th largest company in the world by revenue and 301st in Taiwan.
Revenue (ttm)
19.02B
Revenue Growth
+4.00%
P/S Ratio
0.46
Revenue / Employee
42.65M
Employees
446
Market Cap
8.67B
Revenue by Geography
- Taiwan 18.85B 99.8%
- Malaysia 30.26M 0.2%
- Mainland China 16.06M 0.1%
Fiscal year ended Dec 31, 2025 See the full Great Tree Pharmacy breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 18.90B | 1.62B | 9.39% |
| Dec 31, 2024 | 17.27B | 1.13B | 7.00% |
| Dec 31, 2023 | 16.14B | 1.58B | 10.84% |
| Dec 31, 2022 | 14.56B | 3.28B | 29.11% |
| Dec 31, 2021 | 11.28B | 2.64B | 30.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 20.75B |
| Standard Chemical & Pharmaceutical | 7.08B |
| InnoCare Optoelectronics | 2.75B |
| Bioteque | 2.22B |
| PharmaEngine | 1.03B |
| TCM Biotech International | 701.63M |
| Tanvex BioPharma | 657.56M |
| Caliway Biopharmaceuticals | 29.39M |